In conclusion, the combination of end-stage renal disease, removal of pyridoxal phosphate by hemodialysis, and deleterious NAT2 polymorphisms, contributed to the severe toxicity of isoniazid in our patient. The gene discussed is NAT2; the disease is stage 5 chronic kidney disease.